Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.

Solid-state batteries could enable 600-mile EVs and reduce fires. Now, battery makers are racing to get them over the finish ...

Commonwealth Fusion Systems, which has raised more than $2 billion, mostly from private investors, will need billions more to ...

Elon Musk might not go ahead with his $97.4 billion bid for OpenAI’s nonprofit arm if the ChatGPT maker ceases its transition ...

Together, we are building a nationally preeminent university that will shape the future of education, research, health ...

Bioceres Crop Solutions Corp. Q2 sees 24% revenue drop amid Argentina's crisis. Click here to find out why I maintain a Hold ...

"What we're building at Bull Run is not a science project," an executive from the Knoxville-based nuclear fusion company said.

MaxCyte's technology will support TG Therapeutics' efforts to develop a CD19 CAR T cell therapy program for autoimmune diseases.

Generations have passed without leaving a mark. It’s time to change that and create something that can resonate with both the ...

The 350 MWe fusion pilot power plant could offer a complementary source of base load electrical generation for the region as ...

New agreement between Type One Energy and Tennessee Valley Authority marks a key step in joint effort to commercialize ...

Gevo, Inc. (Englewood, Colo.) and Axens (Rueil-Malmaison, France) have formed a new strategic alliance to accelerate development and commercialization of ...